10x Genomics is hiring a Clinical Laboratory Scientist/Technical Supervisor to oversee next-generation sequencing (NGS) assays in a CLIA-certified lab. The role focuses on ensuring compliance, operational excellence, and technical oversight, requiring specific licensing and extensive experience in molecular diagnostics
Job Summary
This role establishes a diagnostics effort to translate single-cell and spatial genomics technologies into impactful clinical applications within a CLIA-certified laboratory.
The Technical Supervisor serves as the subject matter expert for assay validation, quality systems, and troubleshooting while ensuring operational excellence.
Candidates will collaborate with cross-functional teams including bioinformatics, R&D, and quality to support assay optimization and innovation.
Matching Summary
Match Score: 85
10x Genomics is hiring a Clinical Laboratory Scientist/Technical Supervisor to oversee next-generation sequencing (NGS) assays in a CLIA-certified lab. The role focuses on ensuring compliance, operational excellence, and technical oversight, requiring specific licensing and extensive experience in molecular diagnostics.
Salary
Base: $158,400 - $214,400 USD; Bonus/Equity: Eligible for equity grants and annual bonus program; Benefits: Comprehensive health and retirement benefit programs
Skills & Requirements
Must-have
High complexity next-generation sequencing assays
CLIA CAP regulatory compliance oversight
NGS assay validation and implementation
Technical troubleshooting of bioinformatics pipelines
Quality control and assurance program management
Nice-to-have
Startup or high growth laboratory experience
Background in medical or oncology diagnostics
Strong analytical problem-solving skills
Experience with continuous improvement initiatives
Key Requirements
Active California Clinical Laboratory Scientist (CLS) license
4-6 years experience in CLIA lab molecular diagnostics
Bachelor's degree in chemical, biological, physical, or clinical laboratory science
Meets CLIA Technical Supervisor qualifications under 42 CFR 493.1449